Last month, the stock of coffee shop operator Dutch Bros ( BROS 1.55%) acted as if it had been given a shot of particularly strong espresso. The company's shares zoomed almost 14% higher in April, ...

Strides Pharma Science has agreed to acquire and in license a portfolio of branded generic medicines from Sandoz, strengthening its presence across Sub Saharan Africa. The deal, valued at about 12 ...

NEW DELHI: In what could be good news for patients, Indian Patent Office (IPO) has rejected MNC AbbVie’s patent application for its blockbuster cancer drug Venetoclax citing lack of inventive step.

As the global pharmaceutical landscape undergoes rapid change with advances in novel drug discovery, smarter manufacturing, and shifting trade policies, India is uniquely positioned to lead this ...

Higher sales of Revlimid are set to drive growth for US-focused companies such as Aurobindo Pharma Ltd, Dr Reddy’s Laboratories Ltd and Sun Pharmaceutical Industries Ltd in Q4 and the first few ...

A study linking Indian generic drugs to a higher risk of serious side effects in the US has spurred backlash from the Indian Pharmaceutical Alliance, which refuted the study's claims. The study found ...

Generic drug suppliers weigh predictable and unpredictable factors that could impact the category in 2025. “This is the latest example of our actions to expand our portfolio in growing therapeutic ...

Piramal Pharma Ltd, which has a strong presence in the inhaled anaesthetic generics segment in the US and emerging markets, plans to expand its pipeline of injectables to drive growth, chairperson ...

Add Yahoo as a preferred source to see more of our stories on Google. The drugs were first approved to treat type 2 diabetes – and that's what the FDA said daily injections of liraglutide could be ...